Is an EGM required for a rights issue in Egypt?

It depends on the company’s articles of association. Under Companies Law No. 159/1981, a capital increase is an extraordinary matter that defaults to shareholder approval. However, if the AoA delegate capital-increase authority to the board within defined limits and the proposed issue falls within those limits, the board can approve the rights issue without an EGM. Where an AoA amendment, pre-emption waiver or new share class is involved, an EGM is always required.

How do you apply for a rights issue on the EGX?

The issuer submits a filing package to the EGX comprising certified board or EGM minutes, a letter of offer (or prospectus), auditor and legal-adviser confirmations in the format required by the 2026 FRA rules, and MCDR instructions for the record date and rights ISIN creation. The FRA must also be formally notified. The EGX reviews the package and, once satisfied, authorises the listing of the rights entitlements and, subsequently, the new shares.

What documents must be filed with the FRA and EGX for a rights issue?

The core documents include: notarised EGM or certified board minutes; updated Commercial Registry extract; auditor confirmation letter (2026 format); legal-adviser declaration; final letter of offer or prospectus; MCDR record-date confirmation; and the ISIN allocation notice for the tradeable rights.

Can shareholders waive pre-emption rights in Egypt?

Yes. Pre-emption rights can be waived, but only by an extraordinary general meeting resolution. The waiver must specify the number of shares affected, the proposed allottees or allocation basis, and the pricing terms. The resolution must be notarised and filed with the Commercial Registry and the FRA.

When is a valuation or fairness opinion required for a rights issue?

A valuation or fairness opinion is required when the rights issue involves related-party subscriptions, when shares are priced at a discount to the prevailing market value, or when the transaction could trigger a mandatory tender offer or affect the company’s continued listing eligibility. The FRA’s 2026 amendments strengthen this requirement by mandating that auditor confirmations explicitly address pricing fairness in these circumstances.

How are rights traded on the EGX?

Once the MCDR establishes the record date, shareholders on the register receive tradeable rights entitlements under a dedicated ISIN. These rights trade on the EGX during a renunciation window that typically lasts 10 to 15 trading days. Shareholders who do not wish to subscribe can sell their rights on the exchange. At the end of the subscription period, the rights ISIN is cancelled and the new ordinary shares are listed under the company’s existing share ISIN.

When should issuers consider a private placement rather than a rights issue?

A private placement may be preferable when speed is critical (rights issues involve longer timetables due to the subscription and renunciation windows), when the issuer has identified a strategic investor and wishes to allocate shares directly, or when the capital increase is small enough that the cost and complexity of a full rights-issue process are disproportionate. However, a private placement that disapplies statutory pre-emption requires an EGM waiver resolution, and the EGX may impose different disclosure and lock-up requirements. The choice between the two structures should be assessed against both corporate-law and capital-markets-regulatory considerations.

Is Egm Required For Rights Issues

Whether an EGM is required for rights issues in Egypt depends on the scope of authority the company’s articles of association (AoA) delegate to the board and on the specific capital-increase mechanism chosen. Under Companies Law No. 159 of 1981, the primary statute governing joint stock companies, a capital increase by rights issue generally requires an extraordinary general meeting resolution unless the AoA expressly empower the board to increase capital within defined limits.

The 2026 amendments to the Financial Regulatory Authority’s (FRA) listing and delisting rules have introduced additional auditor-confirmation and governance requirements that affect both documentation timelines and the circumstances in which the Egyptian Exchange (EGX) may insist on shareholder approval even where the Companies Law might otherwise permit board action. This guide consolidates statutory rules, EGX/FRA practice and step-by-step filing logistics into a single reference for issuers, advisers and company secretaries navigating a rights issue on the EGX in 2026.

Quick checklist, what this article covers:

When Egyptian law mandates an EGM versus when a board resolution suffices for a capital increase by rights issue
EGX filing packages, FRA notifications and the impact of the 2026 FRA listing-rule amendments
A day-by-day procedural timeline from first board meeting to trading of new shares
Pre-emption rights, waivers and a comparison of rights issues versus private placements
Sample resolution language, pitfall alerts and an adviser-ready checklist

When Is Shareholder Approval (an EGM) Required for a Rights Issue in Egypt?

Statutory baseline, Companies Law No. 159/1981

Companies Law No. 159 of 1981 and its executive regulations set out the framework for capital increases. The statute provides that increasing the issued share capital of a joint stock company is a matter that amends the company’s constitutional documents and therefore falls, by default, within the competence of the extraordinary general meeting. The same law enshrines pre-emption rights for existing shareholders: when new shares are issued for cash, current holders must be offered the right to subscribe in proportion to their existing stakes before shares can be offered to third parties. These statutory pre-emption rights in Egypt are a cornerstone of minority shareholders’ protection and can only be disapplied through a valid shareholder resolution.

Crucially, however, the Companies Law permits the AoA of a joint stock company to delegate to the board the authority to resolve on capital increases within specified parameters, for example, up to a stated percentage of authorised capital, within a defined time window, or subject to a price floor. Where such delegation exists and has not been exhausted, the board may approve a rights issue without convening an extraordinary general meeting.

Common triggers that make an EGM mandatory

Even where the AoA contain a delegation clause, certain circumstances will require the issuer to return to shareholders via an EGM. The most frequent triggers include:

Exceeding delegated limits. If the proposed capital increase exceeds the monetary ceiling or the maximum number of shares the board is authorised to issue, an EGM resolution is required.
Amendment to the AoA. Any rights issue that necessitates amending the articles, for instance, changing the authorised capital figure, altering share-class structures or revising nominal value, is an extraordinary matter requiring shareholder approval.
Waiver of pre-emption rights. Disapplying statutory pre-emption in favour of a targeted allocation (effectively converting a rights issue into a partial private placement) requires an EGM resolution.
Issuance of a new share class. Creating preference shares or any class with rights different from existing ordinary shares necessitates an extraordinary resolution.
Related-party transactions. Where the capital increase involves subscriptions by related parties on terms that differ from market pricing, FRA practice and good governance standards compel shareholder approval.

Practical board-vs-EGM decision test

Advisers can apply a three-step rule of thumb to determine whether an EGM is required for a rights issue in Egypt:

Check the AoA delegation clause. Does the board have unexpired, unused authority to increase capital? If no, EGM required.
Assess whether the issue changes constitutional terms. Will the AoA need amendment, or will pre-emption rights be waived? If yes to either, EGM required.
Review EGX/FRA listing conditions. Even with valid board authority, does the EGX or FRA impose a shareholder-approval condition for the specific listing change? If yes, EGM required.

EGX and FRA Practice, Approvals, Filings and 2026 Amendments That Matter

What the EGX requires for a rights issue listing

For a rights issue on the EGX, the issuer must submit a comprehensive filing package to the exchange. This typically includes certified copies of the relevant board or EGM resolution, a letter of offer (or a prospectus, where the issue size or circumstances require one), updated audited financial statements, a legal adviser’s confirmation of the validity of the corporate authorisation, and instructions to the central depository (Misr for Central Clearing, Depository and Registry, MCDR) for establishing a record date and generating a new ISIN for the tradeable rights entitlements. The EGX will not admit the new shares to listing until it has received evidence that all statutory and regulatory approvals have been obtained and all subscription mechanics are in place.

FRA 2026 listing-rule amendments, what has changed

The FRA’s 2026 amendments to the listing and delisting rules, designed to strengthen governance and investor protection, have introduced several changes with direct relevance to rights issues. Industry observers expect the practical effects to include:

Enhanced auditor confirmations. Issuers must now submit independent auditor confirmations that specifically attest to the adequacy of disclosures in the letter of offer and the accuracy of the financial data underpinning the pricing of new shares.
Legal-adviser declarations. A formal declaration from the issuer’s legal adviser confirming that all corporate authorisations (board or EGM) comply with the Companies Law and the company’s AoA is now a mandatory filing component.
Governance disclosures. Additional disclosure requirements regarding related-party participation, board-member interests and the rationale for any pricing at a discount to market value.
Timeline adjustments. The amended rules tighten processing windows for FRA review, which may compress the overall timetable for bringing rights to market on the EGX.

These FRA amendments to the EGX listing rules reinforce the need for issuers to engage auditors and legal advisers earlier in the process than was previously standard practice.

When the EGX insists on an EGM despite valid board authority

Market practice shows that the EGX may require evidence of shareholder approval in situations where the rights issue materially changes the company’s listing characteristics, for example, where the issue would dilute existing free float below minimum listing thresholds, where the issue is coupled with a change in the company’s sector classification, or where the pricing terms raise investor-protection concerns. In these cases, even a technically valid board delegation may be insufficient to satisfy the EGX listing requirements, and the issuer will be directed to obtain an EGM resolution before proceeding with the capital increase on the EGX.

Step-by-Step Procedural Checklist: Board Meetings, EGM Notices, Filings and EGX Timetable

The following timeline illustrates how to apply for a rights issue on the EGX, from initial board decision to trading of the new shares. Actual timings depend on whether an EGM is needed and on FRA/EGX review periods.

Stage	Indicative timing	Key actions
1. Board Meeting 1	Day 0	Resolve to pursue the capital increase. If AoA delegation exists and limits are not exceeded, approve the rights issue directly. If not, resolve to convene an EGM. Engage legal adviser and auditor.
2. EGM notice	Day 1–15	Publish notice in the Commercial Gazette and a daily newspaper. The notice period under the Companies Law is a minimum of 15 days before the meeting date. Include agenda, proposed resolution text, venue and quorum details.
3. EGM	Day 15–20	Hold the extraordinary general meeting. Achieve the required quorum and voting threshold. Record minutes, have them notarised and submit certified copies to the Commercial Registry and the General Authority for Investment and Free Zones (GAFI).
4. Board Meeting 2	Day 20–25	Ratify allotment terms: fix the issue ratio, subscription price, renunciation rights, subscription period duration and record date.
5. Letter of Offer / Prospectus preparation	Day 25–40	Draft the letter of offer (or prospectus). Obtain auditor confirmations and legal-adviser declarations as required by the 2026 FRA rules. Submit draft to FRA for review.
6. EGX filing and FRA notification	Day 40–50	File the full submission package with the EGX: certified board/EGM minutes, letter of offer, auditor and legal confirmations, MCDR instructions. Notify the FRA formally.
7. Record date and ISIN creation	Day 50–55	MCDR establishes the record date. Shareholders on the register at the record date receive rights entitlements. A new ISIN is generated for the tradeable rights.
8. Trading and subscription	Day 55–75+	Rights trade on the EGX during the renunciation window (typically 10–15 trading days). Subscription period runs concurrently or immediately after. At close of subscription, unsubscribed shares are allocated per the terms of the offer.
9. Allotment and settlement	Day 75–85+	Board confirms final allotment. MCDR converts rights ISINs to ordinary-share ISINs. New shares are admitted to listing and begin trading.

Documents requiring original certified copies for EGX/FRA filing:

Notarised EGM minutes (or certified board resolution if EGM not required)
Updated Commercial Registry extract reflecting the capital increase
Auditor confirmation letter (2026 FRA format)
Legal-adviser declaration on corporate authorisation validity
Final letter of offer / prospectus stamped by the FRA
MCDR record-date confirmation and ISIN allocation notice

Pre-Emption Rights, Waivers and Rights Issue vs Private Placement Comparison

Pre-emption rights in Egypt are statutory: under Companies Law No. 159/1981, existing shareholders of a joint stock company are entitled to subscribe for new shares issued for cash in proportion to their existing holdings. These rights attach automatically and do not require activation by the board or AoA. However, pre-emption can be waived by an extraordinary general meeting resolution, a critical point for issuers considering whether a full rights issue or a targeted private placement better serves the company’s capital-raising objectives.

Issue	Rights Issue	Private Placement
Shareholder pre-emption	Existing shareholders have statutory pre-emption unless validly waived by EGM resolution	No statutory pre-emption applies; however, contractual or AoA-level restrictions may exist
Approval threshold	EGM required if AoA do not delegate authority or if delegation limits are exceeded; board resolution suffices where valid delegation exists	Usually board resolution plus shareholder notice, depending on AoA and FRA-regulated rules
EGX/FRA treatment	Requires EGX filing, letter of offer, ISIN for rights; EGX may require EGM approval for certain listing changes	EGX pre-clearance may be needed for listed companies; different disclosure and lock-up expectations apply

Drafting pre-emption waivers. A waiver resolution should specify the exact number of shares to which pre-emption is being waived, the identity of the proposed allottees (if known), and the pricing basis. Record the full text in notarised EGM minutes and file with both the Commercial Registry and the FRA. Failure to follow this procedure can expose the issuer to challenges from minority shareholders.

Common Pitfalls, Auditor and Legal Confirmations, Valuation and Fair Price Issues

Several recurring pitfalls delay or derail rights issues on the EGX. Advisers should be alert to the following:

Valuation and fairness opinions. A formal valuation or fairness opinion is required where the rights issue involves related-party subscriptions, where shares are issued at a discount to the prevailing market price, or where the transaction could trigger delisting or a mandatory tender offer. The FRA’s 2026 amendments reinforce this requirement by mandating that the auditor’s confirmation letter expressly address pricing fairness where any of these circumstances exist.
Timing of auditor and legal-adviser engagement. Under the new FRA rules, auditor and legal-adviser confirmations must be in a prescribed format and must reference the 2026 listing-rule requirements. Late engagement of these professionals is among the most common causes of EGX filing delays.
Incomplete Commercial Registry filings. The EGX will not process a rights issue application if the issuer’s Commercial Registry extract does not reflect the most recent approved capital figure. Issuers should update the registry immediately after the EGM or board resolution.
Free-float dilution. If the rights issue would reduce the company’s free float below the EGX minimum listing threshold, additional regulatory approvals or restructuring steps may be needed before the issue can proceed.

Templates and Sample Language for Board Resolutions, EGM Resolutions and Pre-Emption Waivers

The following templates provide starting-point language. Each must be adapted to the company’s specific AoA, the terms of the proposed capital increase, and the requirements of the EGX and FRA at the time of filing.

1. Board resolution, capital increase under delegated authority

“RESOLVED that, pursuant to Article [●] of the Company’s Articles of Association and within the limits of the authority delegated to the Board by the Extraordinary General Meeting held on [date], the Board hereby approves an increase in the Company’s issued share capital from EGP [●] to EGP [●] by the issuance of [●] new ordinary shares of EGP [●] nominal value each, to be offered to existing shareholders by way of rights issue at a subscription price of EGP [●] per share.”

2. EGM resolution, capital increase requiring shareholder approval

“RESOLVED, by way of extraordinary resolution, that the issued share capital of the Company be increased from EGP [●] to EGP [●] by the creation and allotment of [●] new ordinary shares of EGP [●] nominal value each, to be offered to existing shareholders pro rata to their holdings by way of rights issue, at a subscription price of EGP [●] per share, and that Article [●] of the Company’s Articles of Association be amended accordingly.”

3. EGM resolution, waiver of pre-emption rights

“RESOLVED, by way of extraordinary resolution, that the statutory pre-emption rights of existing shareholders under Companies Law No. 159 of 1981 be waived in respect of [●] new ordinary shares of EGP [●] nominal value each, to be allocated to [identify allottees or describe allocation basis] at a subscription price of EGP [●] per share, and that the Board be authorised to take all steps necessary to implement this resolution.”

EGM Obligations by Entity Type and Trigger

The requirement for an extraordinary general meeting in Egypt varies by entity type. The following table summarises the position for the three most common corporate structures.

Entity type	When EGM is needed for a capital increase	Typical required vote
Listed joint stock company (SAE, listed on EGX)	Required unless AoA delegate authority to the board within defined limits; EGX may impose additional shareholder-approval conditions	Extraordinary resolution, typically a two-thirds supermajority of shares represented at the meeting, subject to quorum
Unlisted joint stock company (SAE, not listed)	Required unless AoA delegation exists; no EGX overlay, but GAFI and Commercial Registry filings still apply	Two-thirds supermajority of shares represented, subject to quorum requirements under the Companies Law
Limited liability company (LLC)	Partners’ meeting required for any amendment to the memorandum of association, including capital increases; no delegated-authority mechanism equivalent to SAE practice	Approval of partners holding at least three-quarters of the company’s capital (unless the memorandum specifies a higher threshold)

For issuers structured as joint stock companies and listed on the EGX, the interaction between the Companies Law, the AoA delegation clause and EGX listing requirements creates the most complex approval matrix. Advisers should map all three layers before advising on whether an EGM is required for the specific rights issue under consideration.

Practical Checklist for Advisers and Timeline Playbook

The following checklist distils the key decision points and red flags that force an EGM for a capital increase on the EGX:

Confirm whether the AoA contain a valid, unexpired board delegation for capital increases
Verify that the proposed issue size falls within the monetary and share-number limits of any delegation
Determine whether pre-emption rights will be maintained or waived, waiver requires EGM
Check whether the issue involves related-party subscriptions or pricing at a discount, triggers enhanced FRA documentation and likely EGM
Assess impact on free float and EGX minimum listing thresholds
Engage auditor and legal adviser immediately after the first board meeting, 2026 FRA confirmation requirements extend lead times
Prepare notarised minutes in the correct format for both the Commercial Registry and the EGX
Allow a minimum of 60–85 days from initial board decision to first day of rights trading under normal circumstances

Red flags that always force an EGM: no AoA delegation clause; delegation exhausted or expired; AoA amendment needed; new share class; pre-emption waiver; EGX direction based on listing-eligibility concerns.

Conclusion

Determining whether an EGM is required for rights issues in Egypt is not a binary question, it hinges on the interplay between the company’s AoA delegation clause, the scope of the proposed capital increase, and the regulatory overlay imposed by the EGX and the FRA. The 2026 FRA listing-rule amendments have raised documentation standards and compressed review timelines, making early adviser engagement essential. Issuers planning a capital increase on the EGX should map the three-layer approval test set out in this guide, prepare filings to the 2026 standard from the outset, and build a realistic 60-to-85-day timeline into their capital-raising plans.

Need Legal Advice?

This article was produced by Global Law Experts. For specialist advice on this topic, contact Omneya Anas at Shalakany, a member of the Global Law Experts network.